Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's)
Lymphoma, Large B-Cell, Diffuse
RTX is an effective treatment for ENT manifestations of GPA. Subjects treated with RTX were significantly less likely to have active ENT disease compared with those not receiving RTX. Patients being treated with RTX were 11 times less likely to have active ENT disease than patients being treated with other therapies.